Clinical effect of live combined bifidobacterium,lactobacillus and enterococcus powder treatment in children with secondary diarrhea of pneumonia and analysis of related factors
10.3760/cma.j.issn.1673-4904.2013.12.012
- VernacularTitle:双歧杆菌三联活菌散治疗小儿肺炎继发腹泻的临床疗效及其影响因素分析
- Author:
Qing SU
;
Yongxing ZHONG
- Publication Type:Journal Article
- Keywords:
Pneumonia;
Diarrhea;
Child
- From:
Chinese Journal of Postgraduates of Medicine
2013;(12):33-35
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical effect of live combined bifidobacterium,lactobacillus and enterococcus powder (probiotics bifico) treatment in children with secondary diarrhea of pneumonia and analysis of related factors.Methods Three hundred and eighty-five pneumonia children were studied.The related factors of secondary diarrhea of pneumonia were screened.One hundred and twenty cases of children with secondary diarrhea of pneumonia were divided into observation group and control group by table of random digit with 60 cases each.The observation group was given the probiotics bifico combined with conventional treatment,the control group was given the conventional treatment.The clinical efficacy was evaluated treatment after 7 d.Results The effective rate of observation group was significantly higher than that of control group [96.7％(58/60) vs.61.7％(37/60),x2 =22.282,P＜ 0.01].Age of onset,hospitalization time,invasive procedures,combination therapy of antibiotics,therapy of hormone and therapy of probiotics bifico were related with the incidence of secondary diarrhea of pneumonia (P ＜ 0.01 or ＜ 0.05).Conclusions The younger children,long hospital stay,invasive procedures,combination therapy of antibiotics and therapy of hormone are the risk factors of secondary diarrhea of pneumonia.The probiotics bifico for treating the children with secondary diarrhea of pneumonia has exact clinical efficacy,and it is worthy of clinical application.
